Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Birth control pills can help reduce mild to moderate acne in women.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Testosterone helps human pancreatic cells increase insulin release.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.